President Donald Trump unwrapped a massive drug pricing policy as CMS prepares for the next round of Medicare drug price negotiations; Vinay Prasad to take the helm at the FDA’s Center for Biologics ...

Inspired by the world's great Lego Masters, Arovella is taking a brick-by-brick approach to building its unique cancer ...

Nearly 600 attendees learned about life sciences industry trends and heard from 93 presenting biotechnology companies at ...

The FDA has issued a complete response letter (CRL) to Merck & Co's gefapixant candidate for refractory chronic cough, delaying the programme and giving Bayer an opportunity to close the gap with ...

Priorix was first launched in Europe almost a quarter of a century ago by GSK's predecessor SmithKline Beecham, and is a combination measles, mumps and rubella (MMR) vaccine now cleared by the FDA ...

Japanese drugmaker Takeda has suffered a blow to its late-stage pipeline, after the FDA rejected its marketing application for TAK-721, a drug candidate that is trying to be the first approved ...

In the space of four days, the number of FDA-approved therapies for ultra-rare genetic disorder Niemann-Pick disease has gone from zero to two, transforming the prospects for patients. IntraBio's ...

The FDA has approved Amgen’s cheaper Humira biosimilar, Amjevita, but launch could be delayed by up to three years after AbbVie launched a legal challenge earlier this month.

Novo Nordisk applied to the FDA for approval of semaglutide in obesity in December, using an acquired priority voucher to speed up the review time. Looming on the horizon is Lilly's tirzepatide ...

It seems Eisai and Biogen have another hurdle to jump over in their bid to get EU approval for their Alzheimer's disease therapy Leqembi. In the latest development, the European Commission has ...

The pharmaceutical construction industry has seen explosive growth, a trend with substantial implications for healthcare industry, and global health outcomes. The COVID-19 pandemic underscored the ...

Effective KOL management is more than just tracking which activities your KOLs have engaged with. It’s also about tracking the effectiveness of those activities, and the resulting impact on KOL ...